Kroger Co vs Novavax Inc — how do they compare? Kroger Co trades at $58.57 (market cap $35.75B), while Novavax Inc trades at $7.9 (market cap $1.30B). The key difference: Kroger Co is far larger — about 27.5× Novavax Inc's market cap, and Kroger Co pays a 2.47% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| KR | NVAX | |
|---|---|---|
Market Cap | $35.75B | $1.30B |
Sector | Consumer Staples | Health |
52-Week High | $75.60 | $11.19 |
52-Week Low | $55.53 | $6.22 |
Enterprise Value | $55.85B | $800.50M |
Dividend Yield | 2.47% | — |
Trailing returns across standard periods
Latest headlines on both assets
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →